Abilify Gambling Lawsuits Look To Study Revealing Increased Risk For Gambling Disorders


Abilify Gambling Lawsuits Allege Users of The Antipsychotic Medication Develop Gambling And Other Impulse Control Disorders

abilify-compulsive-gambling-lawsuit-side-effects-lawsuits-bottleAs Abilify gambling lawsuits continue to mount nationwide, a new study confirms claims that the antipsychotic drug causes compulsive gambling disorders. Over 40 Abilify gambling lawsuits are consolidated in a multidistrict litigation (MDL) accusing Otsuka Pharmaceuticals and Bristol-Myers Squibb, which makes and markets Abilify, of failing to properly warn consumers that the medication used to treat schizophrenia, bipolar disorder, and certain other mental conditions is associated with impulsive control disorders. (In Re: Abilify (Aripiprazole) Products Liability Litigation – Abilify Gambling Lawsuits MDL 2734)

The drugs Abilify (aripiprazole), Mirapex (pramipexol), and Requip (ropinirole) were involved in the study. Mirapex and Requip are used to treat Parkinson’s disease and are associated with gambling and other compulsive disorders. Researchers used a large U.S. health claims database and compared 355 cases of gambling disorder with 3,550 corresponding controls and compared 4,341 cases of impulse control disorder with 43,410 corresponding controls. The study showed Abilify users were at five times the risk of pathologic gambling and seven times the risk of impulse control disorder compared to the controls. The risk was also increased for pramipexole or ropinirole for both gambling disorder and impulse control disorder. The study was released online December 7, ahead of the February 2017 print edition of the Journal of Clinical Psychopharmacology.

“Patients who are prescribed Abilify have yet another study that confirms their impulsive disorder behaviors that they claim are a result of taking the medication,” says Wright & Schulte LLC.

Wright & Schulte LLC is offering free Abilify gambling lawsuit evaluations to individuals who allegedly sustained significant financial losses and other damages due to an Abilify gambling addiction or other impulse control problems that may be linked to the medication. Please visit our website at www.yourlegalhelp.com or call 1-800-399-0795 to learn more about your potential legal recourse.

Abilify (aripiprazole) is prescribed to treat schizophrenia, bipolar disorder, Tourette’s disorder, and certain other mental disorders. The medication, approved by the U.S. Food and Drug Administration (FDA) in November 2002, is also used to treat depression. Aripiprazole is available under the brand names Abilify, Abilify Maintena, Aristada, and also as generics. Aripiprazole can decrease hallucinations and other psychotic symptoms such as disorganized thinking, according to the FDA.

Abilify’s label warns that the drug has been linked to compulsive gambling. However, in May, the FDA added new warnings to the label that aripiprazole and its generics can cause compulsive or uncontrollable urges to binge eat, shop, and have sex, in addition to gambling. Since Abiify’s approval, there have been 184 cases reported to the FDA of impulse-control problems associated with the use of Abilify. The federal agency’s database of adverse events reports identified 167 cases in the United States, of which 164 cases involved pathological gambling. The other behaviors included compulsive eating, spending, shopping and sexual behaviors.

Court documents indicate the MDL for federal Abilify gambling lawsuits was established in October in the U.S. District Court, Northern District of Florida. The U.S. Judicial Panel on Multidistrict Litigation found consolidating the cases for coordinated pretrial proceedings would avoid duplicative discovery and prevent inconsistent court rulings. Plaintiffs commonly allege in the complaints that they have suffered financial losses due to their gambling addiction brought on by Abilify. The Abilify gambling complaints also accuse Otsuka Pharmaceuticals and Bristol-Myers Squibb of misrepresenting the antipsychotic drug as safe and effective but failed to warn about the compulsive gambling side effects and other impulse control disorders. (In Re: Abilify (Aripiprazole) Products Liability Litigation – MDL 2734)

About Wright & Schulte LLC And Filing An Abilify Gambling Lawsuit

Wright & Schulte LLC is an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright Schulte LLC stand up for the rights of people who have been injured or wronged, and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, do not hesitate to contact Wright & Schulte LLC today. Free Abilify gambling lawsuit case evaluations are available through yourlegalhelp.com, or call 1-888-399-0795.

Wright & Schulte LLC • 865 S. Dixie Drive • Vandalia, Ohio 45377 • 1-800-399-0795

This entry was posted in Wright & Schulte Lawsuit News. Bookmark the permalink.